Astrana Health (NASDAQ:ASTH) Upgraded to “Overweight” at Barclays

Astrana Health (NASDAQ:ASTH) was upgraded by investment analysts at Barclays from an “equal weight” rating to an “overweight” rating in a report issued on Tuesday. The firm currently has a $50.00 target price on the stock. Barclays‘s price objective would suggest a potential upside of 32.10% from the company’s current price.

A number of other research analysts also recently issued reports on ASTH. Weiss Ratings upgraded shares of Astrana Health from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Truist Financial boosted their target price on shares of Astrana Health from $38.00 to $47.00 and gave the company a “buy” rating in a research report on Thursday, May 14th. BTIG Research boosted their target price on shares of Astrana Health from $40.00 to $50.00 and gave the company a “buy” rating in a research report on Friday, May 8th. Robert W. Baird set a $45.00 target price on shares of Astrana Health in a research report on Friday, May 8th. Finally, Zacks Research upgraded shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 11th. Seven equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, Astrana Health has an average rating of “Moderate Buy” and an average price target of $45.00.

Astrana Health Price Performance

Shares of ASTH opened at $37.85 on Tuesday. The company has a market cap of $2.11 billion, a price-to-earnings ratio of 62.05 and a beta of 0.98. Astrana Health has a twelve month low of $18.08 and a twelve month high of $39.93. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.20. The company has a 50 day moving average of $30.99 and a two-hundred day moving average of $26.15.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Thursday, May 7th. The company reported $0.74 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.45. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The company had revenue of $965.10 million during the quarter, compared to the consensus estimate of $949.21 million. During the same period last year, the firm earned $0.42 earnings per share. Astrana Health’s revenue was up 55.6% compared to the same quarter last year. As a group, analysts predict that Astrana Health will post 1.25 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ASTH. Signaturefd LLC increased its holdings in Astrana Health by 57.9% in the fourth quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after buying an additional 388 shares in the last quarter. GAMMA Investing LLC increased its holdings in Astrana Health by 144.7% in the fourth quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after buying an additional 871 shares in the last quarter. Strs Ohio purchased a new position in Astrana Health in the fourth quarter valued at $40,000. Tower Research Capital LLC TRC increased its holdings in Astrana Health by 323.3% in the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after buying an additional 3,517 shares in the last quarter. Finally, State of Wyoming purchased a new position in Astrana Health in the second quarter valued at $132,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.